Banci L, Bertini I, Luchinat C. Nuclear and electron relaxation. The Magnetic Nucleus-Unpaired Electron Coupling in Solution. Weinheim: Wiley-VCH; 1991.
Merbach AE, Toth E. The Chemistry of Contrast Agents in MedicalMagnetic Resonance Imaging.Wiley; 2001.
Muller RN, Vanderelst L, Roch A, Peters JA, Csajbok E, et al. Relaxation by metal containing nanosystems. Adv Inorg Chem 2005, 57:239-292.
Bulte JW, Kraitchman DL. Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed 2004, 17:484-499.
Gossuin Y, Muller RN, Gillis P. Relaxation induced by ferritin: a better understanding for an improved MRI iron quantification. NMR Biomed 2004, 17:427-432.
Brittenham GM, Badman DG. Noninvasive measurement of iron: report of an NIDDK workshop. Blood 2003, 101:15-19.
Cornell RM, Schwertmann U. The Iron Oxides: Structure, Properties, Reactions, Occurrences and Uses. Weinheim: Wiley-VCH; 2003.
Ńeel L. Magnetic properties of ferrites: ferrimagnetism and antiferromagnetism. Ann Phys (Paris) 1948, 3:137-198.
Harrison PM, Arosio P. The ferritins: molecular properties, iron storage function and cellular regulation. Biochim Biophys Acta 1996, 1275:161-203.
Michel FM, Ehm L, Antao SM, Lee PL, Chupas PJ, et al. The structure of ferrihydrite, a nanocrystalline material. Science 2007, 316(5832):1726-1729.
Ńeel, L. Superparamagnetisme de grains tres fins antiferromagnetiques. C R Acad Sci 1961 252 40754080.Translated in Selected Works of Louis Ńeel (Kurti, N, ed.). New York: Gordon and Breach; 1988 107110.
Kilcoyne SH, Cywinski R. Ferritin: a model superparamagnet. J Magn Magn Mater 1995, 140-144:1466-1467.
Dickson DPE. Nanostructured magnetism in living systems. J Magn Magn Mater 1999, 203:46-49.
Gilles C, Bonville P, Wong KKW, Mann S. Non-Langevin behaviour of the uncompensated magnetization in nanoparticles of artificial ferritin. Eur Phys J B 2000, 17:417-427.
Ros PR, Freeny PC, Harms SE, Seltzer SE, Davis PL, et al. Hepatic MR imaging with ferumoxides: a multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions. Radiology 1995, 196:481-488.
Arnold P, Ward J, Wilson D, Guthrie JA, Robinson PJ. Superparamagnetic iron oxide (SPIO) enhancement in the cirrhotic liver: a comparison of two doses of ferumoxides in patients with advanced disease. Magn Reson Imaging 2003, 21:695-700.
Kehagias DT, Gouliamos AD, Smyrniotis V, Vlahos LJ. Diagnostic efficacy and safety of MRI of the liver with Superparamagnetic iron oxide particles (SHU555A). J Magn Reson Imaging 2001, 14:595-601.
Kreft BP, Tanimoto A, Leffler S, Finn JP, Oksendal AN, et al. Contrast-enhanced MR imaging of diffuse and focal splenic disease with use of magnetic starch microspheres. J Magn Reson Imaging 1994, 4:373-379.
Anzai Y, Blackwell KE, Hirschowitz SL, Rogers JW, Sato Y. Initial clinical experience with dextran-coated superparamagnetic iron oxide for detection of lymph node metastases in patients with head and neck cancer. Radiology 1994, 192:709-715.
Bjornerud A, Johansson L. The utility of superparamagnetic contrast agents in MRI: theoretical consideration and applications in the cardiovascular system. NMR Biomed 2004, 17(7):465-477.
Bjerner T, Johansson L, Wikstrom G, Ericsson A, Briley-Soebo K, et al. In and ex vivo MR evaluation of acute myocardial ischemia in pigs by determining R1 in steady state after the administration of the intravascular contrast agent NC100150 injection. Invest Radiol 2004, 39(8):479-486.
Johansson LO, Bjerner T, Bjornerud A, Ahlstrom H, TarloKS, et al.Utility ofNC100150 injection in cardiac MRI. Acad Radiol 2002, 9(suppl 1):S79-S81.
Kellar KE, Fujii DK, Gunther WH, Briley-Saebo K, Bjornerod A, et al. Important considerations in the design of iron oxide nanoparticles as contrast agents for TI-weighted MRI and MRA. Acad Radiol 2002, 9(suppl 1):S34-S37.
Kellar KE, Fujii DK, Gunther WH, Briley-Saebo K, Bjornerud A, et al. NC100150 Injection, a preparation of optimized iron oxide nanoparticles for positivecontrast MR angiography. J Magn Reson Imaging 2000, 11(5):488-494.
Bulte JW, Frank JA. Imaging macrophage activity in the brain by using ultrasmall particles of iron oxide. ANJR Am J Neuroradiol 2000, 21(9):1767-1768.
Hartung A, LisyMR, Herrmann K-H, Hilger I, Schüler D, et al. Labeling of macrophages using bacterial magnetosomes and their characterization by magnetic resonance imaging. J Magn Magn Mater 2007, 311:454-459.
Becker C, Hodenius M, Blendinger G, Sechi A,Hieronymus T, et al. Uptake of magnetic nanoparticles into cells for cell tracking. J Magn Magn Mater 2007, 311:234-237.
Bulte JW, Douglas T, Witwer B, Zhang S-C, Strable E, et al. Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat Biotechnol 2001, 19:1141-1147.
Jaffer F, NahrendorfM, Sosnovik D, Kelly KA, Aikawa E, et al. Cellular imaging of inflammation in atherosclerosis using magnetofluorescent nanomaterials. Mol Imaging 2006, 2(5):85-92.
Zhao M, BeauregardDA, Loizou L, Davletov B, Brindle KM. Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent. Nat Med 2001, 7:1241-1244.
Wadghiri YZ, Sigurdsson EM, Sadowski M, Elliott JI, Li Y, et al. Detection of Alzheimer's amyloid in transgenic mice using magnetic resonance microimaging. Magn Reson Med 2003, 50(2):293-302.
Wang YX, Hussain SM, Krestin GP: Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging. Eur Radiol 2001, 11:2313-2319.
Bulte JW, Vymazal J, Brooks RA, Pierpaoli C, Frank JA. Frequency dependence of MR relaxation times. II. Iron oxides. J Magn Reson Imaging 1993, 3(4):641-648.
Jung CW, Jacobs P. Physical and chemical properties of Superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil. Magn Reson Imaging 1995, 13:661-674.
Bulte JW, Brooks RA, Moskowitz BM, Bryant LH, Frank JA. Relaxometry and magnetometry of the MR contrast agent MION-46 L. Magn Reson Med 1999, 42:379-384.
Bulte JW, Brooks RA, Moskowitz BM, Bryant LH Jr, Frank JA. T1 and T2 relaxometry of monocrystalline iron oxide nanoparticles (MION-46L): theory and experiment. Acad Radiol 1998, 5(suppl 1):S137-S140, discussion S145-S146.
Koenig SH, Kellar KE, Fujii DK, Gunther WH, Briley-Saebo K, et al. Three types of physical measurements needed to characterize iron oxide nanoparticles for MRI and MRA: magnetization, relaxometry, and light scattering. Acad Radiol 2002, 9(suppl 1):S5-S10.
Bjornerud A, Wendland M, Johansson L, Ahlstrom H, Higgins C, et al. Use of intravascular contrast agents in MRI. Acad Radiol 1998, 5(suppl 1):223-225.
Bulte JW, Douglas T, Mann S, Frankel RB, Moskowitz BM, et al. Magnetoferritin: characterization of a novel superparamagnetic MR contrast agent. J Magn Reson Imaging 1994, 4(3):497-505.
Gossuin Y, Roch A, Muller RN, Gillis P. Relaxation induced by ferritin and ferritin-like magnetic particles: the role of proton exchange. Magn Reson Med 2000, 43:237-243.
Vymazal J, Brooks RA, Zak O, McRill C, Shen C, et al. T1 and T2 of ferritin at different field strengths: effect on MRI. Magn Reson Med 1992, 27:368-374.
Vymazal J, Brooks RA, Baumgarner C, Tran V, Katz D, et al. The relation between brain iron and NMR relaxation times: an in vitro study. Magn Reson Med 1996, 35(1):56-61.
Papakonstantinou OG, Maris TG, Kostaridou V, Gouliamos AD, Koutoulas GK, et al. Assessment of liver iron overload by T2-quantitative magnetic resonance imaging: correlation of T2-QMRI measurements with serum ferritin concentration and histologic grading of siderosis. Magn Reson Imaging 1995, 13:967-977.
Ma HL, Xu YF, Qi XR, Maitani Y, Nagai T. Superparamagnetic iron oxide nanoparticles stabilized by alginate: pharmacokinetics, tissue distribution, and applications in detecting liver cancers. Int J Pharm 2008, 354(1-2):217-226.
Lee JH, Huh YM, Jun Y, Seo J, Jang J, et al. Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging. Nat Med 2007, 13(1):95-99.
Wan J, Cai W, Meng X, Liu E. Monodisperse watersoluble magnetite nanoparticles prepared by polyol process for high-performance magnetic resonance imaging. Chem Commun 2007, 47:5004-5006.
Gossuin Y, Roch A, Lo Bue F, Muller RN, Gillis P. Nuclear magnetic relaxation dispersion of ferritin and ferritin-likemagnetic particle solutions: a pH-effect study. Magn Reson Med 2001, 46(3):476-481.
Vymazal J, Zak O, Bulte JWM, Aisen P, Brooks RA. T1 and T2 of ferritin solutions: effect of loading factor. Magn Reson Med 1996, 36(1):61-65.
Gossuin Y, Burtea C, Monseux A, Toubeau G, Roch A, et al. Ferritin-induced relaxation in tissues: an in vitro study. J Magn Reson Imaging 2004, 20:690-696.
Gossuin Y, Gillis P, Muller RN, Hocq A. Relaxation by clustered ferritin: a model for ferritin-induced relaxation in vivo. NMR Biomed 2007, 20(8):749-756.
Gillis P, Koenig SH. Transverse relaxation of solvent protons induced by magnetized spheres: application to ferritin, erythrocytes, and magnetite. Magn Reson Med 1987, 5(4):323-345.
Roch A, Muller RN, Gillis P. Theory of proton relaxation induced by superparamagnetic particles. J Chem Phys 1999, 110:5403-5411.
Freed JH. Dynamic effects of pair correlation functions on spin relaxation by translational diffusion in liquids. II. Finite jumps and independent T1 processes. J Chem Phys 1978, 9:4034-4037.
Ayant Y, Belorizky E, Alizon J, Gallice J. Calculation of spectral density resulting from random translational movement with relaxation by magnetic dipolar interaction in liquids. J Phys A 1975, 36:991-1004.
Koenig SH, KellarKE. Theory of 1/T1 and 1/T2NMRD profiles of solutions of magnetic nanoparticles. Magn Reson Med 1995, 34(2):227-233.
Roch A, Gossuin Y, Muller RN, Gillis P. Superparamagnetic colloid suspensions: water magnetic relaxation and clustering. J Magn Magn Mater 2005, 293:532-539.
Larsen BA, Haag MA, Serkova NJ, Shroyer KR, Stoldt CR. Controlled aggregation of superparamagnetic iron oxide nanoparticles for the development of molecular magnetic resonance imaging probes. Nanotechnology 2008, 19:265102.
Bulte JW, de Cuyper M, Despres D, Frank JA. Preparation, relaxometry, and biokinetics of PEGylated magnetoliposomes as MR contrast agent. J Magn Magn Mater 1999, 194:204-209.
Bowen CV, Zhang X, Saab G, Gareau PJ, Rutt BK. Application of the static Dephasing regime theory to superparamagnetic iron-oxide loaded cells. Magn Reson Med 2002, 48:52-61.
Hartrung A, Lisy MR, Herrmann K-H, Hilger I, Schüler D, et al. Labeling of macrophages using bacterial magnetosomes and their characterization by magnetic resonance imaging. J Magn Magn Mater 2007, 311:454-459.
Rad AM, Arbab AS, Iskander ASM, Jiang Q, Soltanian-Zadeh H. Quantification of superparamagnetic iron oxide (SPIO)-labeled cells using MRI. J Magn Reson Imaging 2007, 26:366-374.
Simon GH, Bauer J, Saborovski O, Fu Y, Corot C, et al. T1 and T2 relaxivity of intracellular and extracellular USPIO at 1.5T and 3T clinical MR scanning. Eur Radiol 2006, 16:738-745.
Brooks RA, Moiny F, Gillis P. On T2-shortening by weakly magnetized particles: the chemical exchange model. Magn Reson Med 2001, 45:1014-1020.
Gossuin Y, Roch A,Muller RN, Gillis P. An evaluation of the contributions of diffusion and exchange in relaxation enhancement by MRI contrast agents. J Magn Reson 2002, 158(1-2):36-42.
Brown RJS. Distribution of fields from randomly placed dipoles: free-precession signal decay as result of magnetite grains. Phys Rev 1961, 121:1379-1382.
Yablonskiy DA, Haacke EM. Theory of NMR signal behavior in magnetically inhomogeneous tissues: the static dephasing regime. Magn Reson Med 1994, 32:749-763.
Gossuin Y, Roch A, Muller RN, Gillis P, LoBlue F. Anomalous nuclear magnetic relaxation of aqueous solutions of ferritin: an unprecedented first-order mechanism. Magn Reson Med 2002, 48(6):959-964.
